Y. Onaran et al., The value of DNA content in predicting the prognosis of thyroid carcinoma in an endemic iodine deficiency region, ACT CHIR B, 99(1), 1999, pp. 30-35
DNA content of tumour was found to correlate with various prognostic factor
s and survival, especially in well differentiated thyroid carcinoma. The ai
m of this investigation was to evaluate the correlation between the DNA plo
idy and the prognosis as well as the survival in thyroid carcinoma in our c
ountry, being an endemic iodine deficiency region.
DNA flowcytometry was performed on paraffin embedded archival tissue blocs
of 74 patients with thyroid carcinoma (70 well differentiated, 3 anaplastic
and Hurthle cell carcinoma) and 12 patients with multinodular goitre. DNA
ploidy was defined as diploidy or aneuploidy.
Aneuploidy was detected in 5 (6.8%) patients with thyroid carcinoma (3 anap
lastic, papillary and 1 Hurthle cell carcinoma). Aneuploidy was significant
ly more frequent in patients with anaplastic carcinoma (n: 3/3, 100%) compa
red to well differentiated thyroid carcinoma (n: 1/70, 1.4%) (p < 0.0001).
Aneuploid DNA content significantly correlated with advanced age (p < 0.01)
, large tumour size (p < 0.001), and low survival (p < 0.01).
Mean survival period of patients with anaplastic carcinoma in whom aneuploi
dy was frequently encountered, was shorter compared to patients with diploi
d well differentiated tumours (p < 0.01).
In conclusion, although anaplastic and follicular carcinoma are more freque
ntly diagnosed in endemic areas, the rate on aneuploidy was found to be low
er in thyroid carcinoma in our country compared to data reported to nonende
mic areas. As the prognostic predictive value of DNA ploidy is reliable in
well differentiated thyroid carcinoma, DNA measurement of FNA biopsy may in
fluence the extent of surgery. Thyroid carcinoma, other than well different
iated types, require radical operations independent of the DNA content. How
ever, adjunctive treatment methods may be used earlier postoperatively acco
rding to quantitative DNA measurement.